糖尿病的经济影响:使用相关的行政数据评估澳大利亚的增量直接成本
Bernard Kwadwo Yeboah Asiamah-Asare1, Sean Randall1, George Mnatzaganian2
1Deakin Health Economics, School of Health and Social Development, Institute for Health Transformation, Deakin University, Burwood, VIC, Australia.
Diabetes & metabolic syndrome
|October 22, 2025
概括
糖尿病在澳大利亚显著增加了医疗保健成本,每年需要额外的73亿澳元. 这种过度负担凸显了针对性干预和资源分配的必要性,以有效管理糖尿病.
科学领域:
- 公共卫生 公共卫生
- 卫生经济学 卫生经济学
- 流行病学 流行病学
背景情况:
- 糖尿病给个人和国家医疗保健基础设施带来了巨大的经济负担.
- 量化澳大利亚与糖尿病相关的直接医疗保健支出对于经济和卫生政策规划至关重要.
研究的目的:
- 确定澳大利亚人口中因糖尿病而增加的直接医疗保健成本.
- 为资源配置和开发有针对性的糖尿病干预提供证据.
主要方法:
- 一个回顾性队列研究,利用西澳大利亚的相关行政数据.
- 18,937名糖尿病患者与基于年龄,性别,偏远和体重状况的对照进行了1:1匹配.
- 政府直接的医疗保健费用 (住院,药物,全科医生访问等). 估计为2021年,并推算到2024年.
主要成果:
- 糖尿病患者的平均年度医疗费用为9677澳元,是没有糖尿病患者的两倍多 (4669澳元).
- 据估计,澳大利亚糖尿病的医疗保健总成本在2024年为142亿澳元,增加成本为73亿澳元.
- 增量成本因人口统计和生活方式因素而有很大差异,包括年龄,偏远地区,体重,社会经济地位和吸烟.
结论:
- 糖尿病对澳大利亚医疗保健系统造成了显著的过度直接医疗保健成本负担.
- 这些发现强调了战略性资源配置和实施有针对性的健康干预措施的必要性,以减轻与糖尿病相关的成本.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes: Management and Pharmacotherapy
861
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
861
Pathophysiology of Diabetes
3.1K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.1K
Insulin: Dosing Regimen and Adverse Effects
677
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
677


